Convalescent Plasma Therapy for Hospitalized Patients With COVID-19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Plasma from donors who have recovered from coronavirus disease 2019 (COVID-19) contain antibodies to SARS-CoV-2 and may be a potential therapy for hospitalized patients with COVID-19. The efficacy of high-titer convalescent plasma for COVID-19, however, still unclear. The present study aims to evaluate the efficacy and safety of using convalescent plasma for treating hospitalized patients with COVID-19.
Epistemonikos ID: 8fb97397affc2c4dd09db26f2104d6570301f1f4
First added on: Oct 15, 2021